2017
DOI: 10.1007/978-1-4939-7477-1_11
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic Profiling of Hsp90 Inhibitors

Abstract: Mass spectrometry assays demonstrate that Hsp90 inhibitors alter the expression of approximately one-quarter of the assayable proteome in mammalian cells. These changes are extraordinarily robust and reproducible, making "proteomics profiling" the gold standard for validating the effects of new Hsp90 inhibitors on cultured cells. Proteomics assays can also suggest novel hypotheses regarding drug mechanisms. To assist investigators in adopting this approach, this Chapter provides detailed protocols for conducti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…Specifically, two-dimensional gel electrophoresis has been employed to analyze protein expression profiles and identify novel diagnostic, prognostic or predictive biomarkers in these tumors [38,39,40,41,42,43,44]. Due to the complex interactome of HSP90 and the enormous number of cellular processes in which it is involved, the use of proteomic tools for the study of this chaperone and its clients is a common approach [17,45,46,47]. However, additional information is needed to dissect responses to HSP90 inhibitors in lung cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, two-dimensional gel electrophoresis has been employed to analyze protein expression profiles and identify novel diagnostic, prognostic or predictive biomarkers in these tumors [38,39,40,41,42,43,44]. Due to the complex interactome of HSP90 and the enormous number of cellular processes in which it is involved, the use of proteomic tools for the study of this chaperone and its clients is a common approach [17,45,46,47]. However, additional information is needed to dissect responses to HSP90 inhibitors in lung cancer.…”
Section: Introductionmentioning
confidence: 99%
“…g ., Voruganti et al). 40 Trypsinolytic peptides were injected onto a 75 μm × 50 cm nanocolumn (Acclaim PepMap, Thermo PN 164942) and separated using a water–acetonitrile gradient (3–30% acetonitrile in 120 min) containing 0.1% formic acid. Peptides were eluted through a stainless steel emitter and ionized within a NanoSpray Flex ion source (Thermo).…”
Section: Methodsmentioning
confidence: 99%
“…From these coomassie-stained gels, the γ-sarcoglycan protein bands were excised and digested with trypsin using standard methodologies (e.g., Voruganti et al). 40 Trypsinolytic peptides were injected onto a 75 μm × 50 cm nanocolumn (Acclaim PepMap, Thermo PN 164942) and separated using a water− acetonitrile gradient (3−30% acetonitrile in 120 min) containing 0.1% formic acid. Peptides were eluted through a stainless steel emitter and ionized within a NanoSpray Flex ion source (Thermo).…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
“…Adsorption reactions were eluted with SDS-PAGE sample buffer and separated on 12% gels. Gels were fractionated and trypsinolyzed as described [40]. For solution digests, resins were eluted with 8M buffered urea, and then the eluates were reduced and alkylated, diluted to 2M urea, and digested with trypsin using standard methods.…”
Section: Lc-ms/msmentioning
confidence: 99%